153 related articles for article (PubMed ID: 34355652)
41. Opposite regulation of vitamin D receptor by ATRA in AML cells susceptible and resistant to vitamin D-induced differentiation.
Gocek E; Marchwicka A; Baurska H; Chrobak A; Marcinkowska E
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):220-6. PubMed ID: 22789609
[TBL] [Abstract][Full Text] [Related]
42. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
43. Lyn, a tyrosine kinase closely linked to the differentiation status of primary acute myeloid leukemia blasts, associates with negative regulation of all-trans retinoic acid (ATRA) and dihydroxyvitamin D3 (VD3)-induced HL-60 cells differentiation.
Iriyama N; Yuan B; Hatta Y; Takagi N; Takei M
Cancer Cell Int; 2016; 16():37. PubMed ID: 27182202
[TBL] [Abstract][Full Text] [Related]
44. Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways.
Lian X; Lin YM; Kozono S; Herbert MK; Li X; Yuan X; Guo J; Guo Y; Tang M; Lin J; Huang Y; Wang B; Qiu C; Tsai CY; Xie J; Gao ZJ; Wu Y; Liu H; Zhou XZ; Lu KP; Chen Y
J Hematol Oncol; 2018 May; 11(1):73. PubMed ID: 29848341
[TBL] [Abstract][Full Text] [Related]
45. The HER2 inhibitor TAK165 Sensitizes Human Acute Myeloid Leukemia Cells to Retinoic Acid-Induced Myeloid Differentiation by activating MEK/ERK mediated RARα/STAT1 axis.
Shao X; Liu Y; Li Y; Xian M; Zhou Q; Yang B; Ying M; He Q
Sci Rep; 2016 Apr; 6():24589. PubMed ID: 27074819
[TBL] [Abstract][Full Text] [Related]
46. Proteomic Profiling of HL-60 Cells during ATRA-Induced Differentiation.
Vakhrushev IV; Novikova SE; Tsvetkova AV; Karalkin PA; Pyatnitskii MA; Zgoda VG; Yarygin KN
Bull Exp Biol Med; 2018 Aug; 165(4):530-543. PubMed ID: 30121918
[TBL] [Abstract][Full Text] [Related]
47. Combined Application of Salinomycin and ATRA Induces Apoptosis and Differentiation of Acute Myeloid Leukemia Cells by Inhibiting WNT/β-Catenin Pathway.
Xi HM; Lu H; Weng XQ; Sheng Y; Wu J; Li L; Cai X
Anticancer Agents Med Chem; 2023; 23(9):1074-1084. PubMed ID: 36627782
[TBL] [Abstract][Full Text] [Related]
48. EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells.
Lainey E; Wolfromm A; Sukkurwala AQ; Micol JB; Fenaux P; Galluzzi L; Kepp O; Kroemer G
Cell Cycle; 2013 Sep; 12(18):2978-91. PubMed ID: 23974111
[TBL] [Abstract][Full Text] [Related]
49. TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid.
Imran M; Park TJ; Lim IK
Eur J Cancer; 2012 Oct; 48(15):2474-85. PubMed ID: 22341854
[TBL] [Abstract][Full Text] [Related]
50. In vitro down-regulation of bcl-2 expression by all-trans retinoic acid in AML blasts.
Pisani F; Del Poeta G; Aronica G; Venditti A; Caravita T; Amadori S
Ann Hematol; 1997 Oct; 75(4):145-7. PubMed ID: 9402847
[TBL] [Abstract][Full Text] [Related]
51. Src family kinase inhibitor bosutinib enhances retinoic acid-induced differentiation of HL-60 leukemia cells.
MacDonald RJ; Bunaciu RP; Ip V; Dai D; Tran D; Varner JD; Yen A
Leuk Lymphoma; 2018 Dec; 59(12):2941-2951. PubMed ID: 29569971
[TBL] [Abstract][Full Text] [Related]
52. The role of the nuclear Akt activation and Akt inhibitors in all-trans-retinoic acid-differentiated HL-60 cells.
Matkovic K; Brugnoli F; Bertagnolo V; Banfic H; Visnjic D
Leukemia; 2006 Jun; 20(6):941-51. PubMed ID: 16617325
[TBL] [Abstract][Full Text] [Related]
53. Combined inhibition of PI3K and mTOR exerts synergistic antiproliferative effect, but diminishes differentiative properties of rapamycin in acute myeloid leukemia cells.
Mise J; Dembitz V; Banfic H; Visnjic D
Pathol Oncol Res; 2011 Sep; 17(3):645-56. PubMed ID: 21336564
[TBL] [Abstract][Full Text] [Related]
54. all-trans-Retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia.
Ozpolat B; Mehta K; Tari AM; Lopez-Berestein G
Am J Hematol; 2002 May; 70(1):39-47. PubMed ID: 11994980
[TBL] [Abstract][Full Text] [Related]
55. Induction of differentiation in acute promyelocytic leukemia cells by 9-cis retinoic acid alpha-tocopherol ester (9-cis tretinoin tocoferil).
Makishima M; Umesono K; Shudo K; Naoe T; Kishi K; Honma Y
Blood; 1998 Jun; 91(12):4715-26. PubMed ID: 9616170
[TBL] [Abstract][Full Text] [Related]
56. Reprogramming acute myeloid leukemia into sensitivity for retinoic-acid-driven differentiation.
van Gils N; Verhagen HJMP; Smit L
Exp Hematol; 2017 Aug; 52():12-23. PubMed ID: 28456748
[TBL] [Abstract][Full Text] [Related]
57. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
[TBL] [Abstract][Full Text] [Related]
58. GSK3 is a regulator of RAR-mediated differentiation.
Gupta K; Gulen F; Sun L; Aguilera R; Chakrabarti A; Kiselar J; Agarwal MK; Wald DN
Leukemia; 2012 Jun; 26(6):1277-85. PubMed ID: 22222598
[TBL] [Abstract][Full Text] [Related]
59. miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid.
Gao SM; Yang J; Chen C; Zhang S; Xing CY; Li H; Wu J; Jiang L
Leuk Lymphoma; 2011 Dec; 52(12):2365-71. PubMed ID: 21838537
[TBL] [Abstract][Full Text] [Related]
60. Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity.
Congleton J; Shen M; MacDonald R; Malavasi F; Yen A
Cell Signal; 2014 Jul; 26(7):1589-97. PubMed ID: 24686085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
